Gerresheimer Shares Rise on Upbeat Outlook and Obesity-Drug Demand
Lead: Gerresheimer's shares surged 13% to EUR101.80 after the company revealed a robust revenue outlook for 2025 and secured...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
Lead: Gerresheimer's shares surged 13% to EUR101.80 after the company revealed a robust revenue outlook for 2025 and secured...
Novo Nordisk is set to release its fourth-quarter results, with net profit expected to rise 52% to 20.64 billion...
German pharmaceutical company Schott Pharma achieved its revenue and earnings targets for the full year, with a boost from...
Abbott Laboratories' stock fell 2% after the company reported fourth-quarter sales that exceeded expectations, driven by strong performance in...
Amid questions about the value of obesity drugs to employers, a report by JPMorgan Chase & Co.'s Morgan Health...
Catalent, a pharmaceutical company, announced at the J.P. Morgan Healthcare Conference that it expects to generate less than $100...
The obesity drug market is set to see more corporate dealmaking, scientific breakthroughs, and improved patient access in 2024,...
Health-care companies, including Novo Nordisk and Eli Lilly, saw a decline in their stock prices as investors shifted their...
Virtual primary care provider LifeMD Inc.'s stock soared 9% after announcing a partnership with wellness company Medifast Inc. to...
Roche, the Swiss drugmaker, has agreed to acquire obesity-drug developer Carmot Therapeutics for up to $3.1 billion. This move...